homology medicines investor relations | Contact Us

Keyword	CPC	PCC	Volume	Score	Length of keyword
homology medicines investor relations	1.61	0.9	7748	32	37
homology	0.46	0.1	7562	36	8
medicines	0.53	0.3	8609	55	9
investor	0.46	0.6	8795	57	8
relations	0.64	0.7	9002	62	9

Keyword	CPC	PCC	Volume	Score
homology medicines investor relations	0.13	0.4	294	83
homology medicines stock price	0.2	0.1	9809	100
homology medicines phone number	1.14	0.5	3660	26
homology medicines inc fixx	0.75	0.2	5152	64
homology medicines clinical hold	0.91	0.1	5282	20
revolution medicines investor relations	0.4	1	461	75
homology medicines oxford biomedica	0.84	0.6	5812	99
medically home stock price	1.06	0.4	5733	21

Search Results related to homology medicines investor relations on Search Engine

Contact Us - Homology Medicines, Inc.
homologymedicines.com

https://www.homologymedicines.com/contact-us/

DA: 32 PA: 64 MOZ Rank: 50

Investor Relations | Homology Medicines, Inc.
homologymedicines.com

https://investors.homologymedicines.com/

Homology’s proprietary platform is designed to utilize its family of 15 human hematopoietic stem cell-derived adeno-associated virus (AAVHSCs) vectors to precisely and efficiently deliver …

DA: 71 PA: 100 MOZ Rank: 21

Home - Homology Medicines, Inc.
homologymedicines.com

https://www.homologymedicines.com/

Homology Medicines Provides Update on pheEDIT and juMPStart Clinical Trials and Announces Expected 2023 Milestones, Including Initial Data Read-Outs from Both Programs. November 10, 2022. Homology Medicines Reports Third …

DA: 54 PA: 63 MOZ Rank: 54

Investors - Homology Medicines, Inc.
homologymedicines.com

https://investors.homologymedicines.com/news-releases/news-release-details/homology-medicines-reports-third-quarter-2021-financial-results

Homology Medicines, Inc. Investors Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases …

DA: 57 PA: 7 MOZ Rank: 79

Investor Calendar | Homology Medicines, Inc.
homologymedicines.com

https://investors.homologymedicines.com/events-and-presentations

Apr 11, 2022 · Investor Calendar | Homology Medicines, Inc. Skip to main navigation About Technology Technology PlatformGene EditingGene TherapyTherapeutic FocusPublications & …

DA: 14 PA: 25 MOZ Rank: 69

Homology Medicines Reports Fourth Quarter and Full Year 2021 …
homologymedicines.com

https://homologymedicines.com/news-story/homology-medicines-reports-fourth-quarter-and-full-year-2021-financial-results-and-recent-highlights

Homology’s proprietary platform is designed to utilize its family of 15 human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver …

DA: 15 PA: 32 MOZ Rank: 74

Homology Medicines to Participate in Upcoming ... - Investor …
homologymedicines.com

https://investors.homologymedicines.com/news-releases/news-release-details/homology-medicines-participate-upcoming-investor-and-patient

Homology Medicines, Inc. Investors Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases …

DA: 90 PA: 59 MOZ Rank: 42

ALERT: Homology Medicines, Inc. Investors with …
prnewswire.com

https://www.prnewswire.com/news-releases/alert-homology-medicines-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit---fixx-301513356.html

Mar 31, 2022 · Homology Medicines, Inc., No. 22-cv-01968 (C.D. Cal.). Commenced on March 25, 2022, the Homology Medicines class action lawsuit charges Homology Medicines as …

DA: 21 PA: 24 MOZ Rank: 81